(Q43948074)

28 November 2017

title

In vivo lung deposition of hollow porous particles from a pressurized metered dose inhaler (English)

1 reference

28 November 2017

7

1 reference

28 November 2017

Peter H Hirst

1

1 reference

28 November 2017

Gary R Pitcairn

2

1 reference

28 November 2017

Jeff G Weers

3

1 reference

28 November 2017

Thomas E Tarara

4

1 reference

28 November 2017

Andrew R Clark

5

1 reference

28 November 2017

Luis A Dellamary

6

1 reference

28 November 2017

Jolene Shorr

8

1 reference

28 November 2017

Stephen P Newman

9

1 reference

28 November 2017

publication date

1 March 2002

1 reference

28 November 2017

published in

Pharmaceutical Research

1 reference

28 November 2017

volume

19

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

258-264

1 reference

Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung.

28 November 2017

cites work

1 reference

12 December 2020

New propellant-free technologies under investigation

1 reference

12 December 2020

Comparison of in vitro and in vivo efficiencies of a novel unit-dose liquid aerosol generator and a pressurized metered dose inhaler.

1 reference

12 December 2020

Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction

1 reference

12 December 2020

Hollow porous particles in metered dose inhalers

1 reference

12 December 2020

Pressurised aerosol deposition in the human lung with and without an "open" spacer device

1 reference

12 December 2020

How well do in vitro particle size measurements predict drug delivery in vivo?

1 reference

12 December 2020

Large porous particles for pulmonary drug delivery

1 reference

12 December 2020

Aerosol deposition in the human lung following administration from a microprocessor controlled pressurised metered dose inhaler

1 reference

12 December 2020

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

1 reference

12 December 2020

Improved targeting of beclomethasone diproprionate (250 micrograms metered dose inhaler) to the lungs of asthmatics with the Spacehaler

1 reference

12 December 2020

Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1014482615914

1 reference

28 November 2017

1 reference